Since it was previously suggested that specific LMP1 variants could be associated with certain pathological conditions, we tested this hypothesis by comparing EBV+ tumor samples (HL and NHL) with EBV+ benign pathology (IM) and healthy carriers (RLH); however no statistical association was disclosed between any particular LMP1 variant and benign or malignant conditions (p>0.05 in each case). Here, PDLIM7 is linked to neoplasm.